Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.

Source:http://linkedlifedata.com/resource/pubmed/id/15561486

Download in:

View as

General Info

PMID
15561486